Skip to content

Parkinson Netzwerk Ostsachsen - a prospective intervention study with embedded subgroup analysis for confirmatory comparison to matched control groups from West Saxony

Parkinson Netzwerk Ostsachsen - a prospective intervention study with embedded subgroup analysis for confirmatory comparison to matched control groups from West Saxony - PANOS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024935
Enrollment
2220
Registered
2021-04-01
Start date
2021-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G20

Interventions

Group 1: Intervention group East Saxony receives the following intervention: - Integration into the PANOS treatment path - Networking of all health care professionals by sharing an intersectoral elect

Sponsors

Universitätsklinikum Carl Gustav Carus DresdenKlinik und Poliklinik für Neurologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: PATIENTS: - Existence of a written declaration of the informed consent after patient information - In the case of patients who are unable to give their consent: a written declaration by the informed consent of the legal representative after caregiver information - Sufficient knowledge of the German language to complete the questionnaires - Age = 18 years - Diagnosis of Parkinson's disease by a specialist in neurology accordingly the criteria of the Movement Disorder Society, certainty of diagnosis "probable ”, e.g. a maximum of two “red flags ”and more supporting criteria than “red flags ”. - Transition phase or late phase of the disease, defined as at least one of the following criteria: o Disturbing morning immobility or decrease in the drug effect at the end of the dose interval (anamnestic) o Occurrence of hypermobility (clinical) o Taking levodopa more than 4 times a day o Unexplained pain o Occurrence of hallucinations (at least once a month) o Cognitive deficits (anamnestic or external anamnestic) o More than one fall - If there is no transition or late phase, one of the following criteria: o Parkinson's tremor despite medication (clinical) o Disturbing daytime sleepiness or sleep disturbances o Impulse control disorder CAREGIVERS: - Relatives, supervisors or other main reference person in the study included patients - Existence of a written declaration of the informed consent after patient information - Sufficient knowledge of German language to complete the questionnaires - Age = 18 years - One caregiver per study patient

Exclusion criteria

Exclusion criteria: PATIENTS: The patient is incapable of giving consent AND does not have a family member with a proxy for health care or a legal representative CAREGIVERS: - Known cognitive impairment or other limitations that make participation in the study impossible (e.g. severely impaired hearing, and/or eyesight, and/or concentration or motor skills)

Design outcomes

Primary

MeasureTime frame
Parkinson's-specific quality of life Assessment using the validated measuring instrument Parkinson's Disease Quality of Life (PDQ) -39 (baseline, after 6 and after 12 months)

Secondary

MeasureTime frame
1. Gait disorder Assessment with the Dresden Fall Frequency Questionnaire (DFQ) 2. Impulse control Assessment with the Questionnaire for impulsive-compulsive behaviors in Parkinson's (QUIP-RS) 3. Depression Assessment with Beck Depression Inventory (BDI II) 4. Psychoses Assessment with the Neuropsychiatric Inventory Questionnaire (NPI-Q) 5. Subjectively perceived quality of care /satisfaction with the care process Assessment with self-developed questionnaire on satisfaction with Parkinson's care 6. Degree of burden on caregivers Assessment with the Parkinson's Disease Caregiver Burden (PDCB)

Countries

Germany

Contacts

Public ContactRobert Bitterlich

Universitätsklinikum Carl Gustav Carus DresdenKlinik und Poliklinik für Neurologie

robert.bitterlich@ukdd.de0351 458-19285

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026